Julie Diana Smith - Jan 1, 2022 Form 3 Insider Report for MERIDIAN BIOSCIENCE INC (VIVO)

Role: Sr VP, Controller, PAO
Signature: /s/ F. Mark Reuter as Attorney-in-Fact for Julie Diana Smith
Stock symbol: VIVO
Transactions as of: Jan 1, 2022
Transactions value $: $0
Form type: 3
Date filed: 1/3/2022, 08:08 AM
Next filing: Oct 5, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	VIVO	Common Stock						25.6K	Jan 1, 2022	By Spouse
holding	VIVO	Common Stock						33K	Jan 1, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	VIVO	Option to Buy							Jan 1, 2022	Common Stock	2K	$6.97	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes restricted share units granted pursuant to the Issuer's shareholder approved equity compensation plan as follows: 1,200 RSUs vesting on 9/16/22; 6,160 RSUs vesting on 11/15/22; 5,411 RSUs vesting on 11/15/23; 5,297 RSUs vesting pro rata over four years beginning 11/4/22; 5,000 RSUs vesting pro rata over four years beginning 12/6/22.